黄连素对肠道黏膜免疫功能的调节作用

被引:20
作者
刘小艺
吕昌龙
机构
[1] 中国医科大学基础医学院免疫学教研室
关键词
黄连素; 肠道黏膜免疫; 免疫细胞; 细胞因子; 信号通路;
D O I
10.13309/j.cnki.pmi.2017.04.016
中图分类号
R285.5 [中药实验药理];
学科分类号
100806 [中药药理学];
摘要
黄连素(berberine)是在中国传统医药中广泛应用的广谱抗菌药物,临床上主要用于治疗肠道细菌感染性疾病。肠道黏膜免疫是机体防止感染的第一道防线,并在宿主与外环境间黏膜稳态的建立和维持上发挥着重要作用。近年来,中医药对肠道黏膜免疫的研究已成为国内外学者的研究热点,现就黄连素在肠道黏膜免疫中的调控作用作一综述。
引用
收藏
页码:76 / 80
页数:5
相关论文
共 23 条
[1]
Berberine differentially modulates the activities of ERK; p38 MAPK; and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice..Cui Guoliang;Qin Xia;Zhang Yuebo;Gong Zhenwei;Ge Baoxue;Zang Ying Qin;.The Journal of biological chemistry.2009,
[2]
Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor..Wang Lihong;Liu Liping;Shi Yan;Cao Hanwei;Chaturvedi Rupesh;Calcutt M Wade;Hu Tianhui;Ren Xiubao;Wilson Keith T;Polk D Brent;Yan Fang;.PloS one.2012,
[3]
Sieving characteristics of cytokine-and peroxide-induced epithelial barrier leak:Inhibition by berberine.[J].Katherine M DiGuilio;Christina M Mercogliano;Jillian Born;Brendan Ferraro;Julie To;Brittany Mixson;Allison Smith;Mary Carmen Valenzano;James M Mullin;.World Journal of Gastrointestinal Pathophysiology.2016, 02
[4]
Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.[J].Hang Zhou;Lili Feng;Fang Xu;Yi Sun;Yuxiang Ma;Xiong Zhang;Hailiang Liu;Ge Xu;Xuefeng Wu;Yan Shen;Yang Sun;Xudong Wu;Qiang Xu.Biomedicine & Pharmacotherapy.2017,
[5]
Berberine ameliorates TNBS induced colitis by inhibiting inflammatory responses and Th1/Th17 differentiation [J].
Li, Chengzhen ;
Xi, Yebin ;
Li, Shan ;
Zhao, Qing ;
Cheng, Wenjing ;
Wang, Zhengting ;
Zhong, Jie ;
Niu, Xiaoyin ;
Chen, Guangjie .
MOLECULAR IMMUNOLOGY, 2015, 67 (02) :444-454
[6]
Berberine Regulates AMP-Activated Protein Kinase Signaling Pathways and Inhibits Colon Tumorigenesis in Mice [J].
Li, Weidong ;
Hua, Baojin ;
Saud, Shakir M. ;
Lin, Hongsheng ;
Hou, Wei ;
Matter, Matthias S. ;
Jia, Libin ;
Colburn, Nancy H. ;
Young, Matthew R. .
MOLECULAR CARCINOGENESIS, 2015, 54 (10) :1096-1109
[7]
Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by suppressing innate and adaptive immune responses.[J].Masaaki Kawano;Rie Takagi;Atsushi Kaneko;Sho Matsushita.Journal of Neuroimmunology.2015,
[8]
The Rhizome Mixture of Anemarrhena asphodeloides and Coptidis chinensis Ameliorates Acute and Chronic Colitis in Mice by Inhibiting the Binding of Lipopolysaccharide to TLR4 and IRAK1 Phosphorylation.[J].Jin-Ju Jeong;Se-Eun Jang;Supriya R. Hyam;Myung Joo Han;Dong-Hyun Kim;Gabino Garrido.Evidence-Based Complementary and Alternative Medicine.2014,
[9]
Berberine prevents damage to the intestinal mucosal barrier during early phase of sepsis in rat through mechanisms independent of the NOD-like receptors signaling pathway.[J].Guo-xun Li;Xi-mo Wang;Tao Jiang;Jian-feng Gong;Ling-ying Niu;Ning Li.European Journal of Pharmacology.2014,
[10]
Berberine acts as a natural inhibitor of Wnt/β-catenin signaling-Identification of more active 13-arylalkyl derivatives [J].
Albring, Kai Frederik ;
Weidemueller, Julia ;
Mittag, Sonnhild ;
Weiske, Joerg ;
Friedrich, Karlheinz ;
Geroni, M. Cristina ;
Lombardi, Paolo ;
Huber, Otmar .
BIOFACTORS, 2013, 39 (06) :652-662